These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8758508)

  • 21. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
    Rajapurkar MM; Gang S; Dabhi M; Kulkarni PS
    J Nephrol; 2007; 20(5):596-601. PubMed ID: 17918146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case of intense cytolysis following the administration of a hepatitis B vaccine].
    Lasheras Carbajo MD; Palacios Díez M; González Diego P; Martín Scapa MA; Cano Ruiz A; Asensio Vegas A
    Rev Clin Esp; 1999 Jan; 199(1):49-50. PubMed ID: 10089783
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hepatitis B immunization in hemodialysis patients].
    Skladaný L; Svác J; Javorský P; Kmet' M
    Vnitr Lek; 1998 Sep; 44(9):535-7. PubMed ID: 10358464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acute transverse myelitis secondary to hepatitis B vaccination].
    Iñiguez C; Mauri JA; Larrodé P; López del Val J; Jericó I; Morales F
    Rev Neurol; 2000 Sep 1-15; 31(5):430-2. PubMed ID: 11027094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B vaccines: use in childhood.
    Moyes CD
    N Z Med J; 1988 Apr; 101(843):165-6. PubMed ID: 2965800
    [No Abstract]   [Full Text] [Related]  

  • 26. Response to hepatitis B vaccination in high risk population.
    Prakash C; Bhatia R; Kumari S; Verghese T; Datta KK
    J Commun Dis; 2000 Mar; 32(1):17-21. PubMed ID: 11129560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New hepatitis B vaccine formulated with an improved adjuvant system.
    Kundi M
    Expert Rev Vaccines; 2007 Apr; 6(2):133-40. PubMed ID: 17408363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune-mediated myelitis following hepatitis B vaccination.
    Stübgen JP
    Autoimmun Rev; 2012 Dec; 12(2):144-9. PubMed ID: 22498789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Vaccines against viral hepatitis B: results and prospects].
    Mukomolov SL
    Tr Inst Im Pastera; 1992; 67():103-15. PubMed ID: 8539762
    [No Abstract]   [Full Text] [Related]  

  • 30. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].
    Zhao YL; Chen YG; Li J; Han GX; Tian C; Liang JL; Li G; Wang ZG; Zhu YG; Tian ZN; Zhang HY; Wan ZJ; Liang ZL; Bi SL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):470-3. PubMed ID: 15231119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
    Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I
    HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective open study of the efficacy of high-dose recombinant hepatitis B rechallenge vaccination in HIV-infected patients.
    de Vries-Sluijs TE; Hansen BE; van Doornum GJ; Springeling T; Evertsz NM; de Man RA; van der Ende ME
    J Infect Dis; 2008 Jan; 197(2):292-4. PubMed ID: 18177248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination against hepatitis B in patients on chronic hemodialysis.
    Kovacic V; Sain M; Vukman V
    Saudi Med J; 2003 Mar; 24(3):311. PubMed ID: 12704514
    [No Abstract]   [Full Text] [Related]  

  • 34. Plasma-derived and recombinant hepatitis B vaccines.
    John TJ
    Indian Pediatr; 1997 Aug; 34(8):745-6. PubMed ID: 9492408
    [No Abstract]   [Full Text] [Related]  

  • 35. Guillain-Barré syndrome following hepatitis B vaccination.
    Khamaisi M; Shoenfeld Y; Orbach H
    Clin Exp Rheumatol; 2004; 22(6):767-70. PubMed ID: 15638054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease.
    Arslan M; Wiesner RH; Sievers C; Egan K; Zein NN
    Liver Transpl; 2001 Apr; 7(4):314-20. PubMed ID: 11303291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunization against viral hepatitis: an obligatory recommendation in consults for sexually transmitted diseases].
    García-Doval I
    Actas Dermosifiliogr; 2007 Mar; 98(2):88-90. PubMed ID: 17397593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness.
    de la Hoz F; Perez L; de Neira M; Hall AJ
    Int J Infect Dis; 2008 Mar; 12(2):183-9. PubMed ID: 17913535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison of immunogenicity and safety of Engerix B and Twinrix vaccine].
    Gałaj A; Grześk G; Borys D; Durmowicz A; Grześk E; Szadujkis-Szadurski L
    Wiad Lek; 2004; 57(5-6):217-20. PubMed ID: 15518064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody response to hepatitis B immunization in infants born to HIV-infected mothers.
    Thaithumyanon P; Punnahitananda S; Praisuwanna P; Thisyakorn U; Ruxrungtham K
    J Med Assoc Thai; 2002 Mar; 85(3):277-82. PubMed ID: 12117014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.